目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 MARKET LIMITATIONS

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.3 GROWTH FORECAST
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 KEY INDUSTRY INSIGHTS
2.6 RESEARCH IMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 STUDY ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 PRESSURE MONITORING MARKET OVERVIEW
4.2 NORTH AMERICA: PRESSURE MONITORING MARKET, BY PRODUCT & COUNTRY (2024)
4.3 PRESSURE MONITORING MARKET: REGIONAL MIX, 2025 VS. 2032
4.4 PRESSURE MONITORING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 PRESSURE MONITORING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of chronic diseases
5.2.1.2 Integration with digital health platforms and rising technological advancements
5.2.1.3 Gradual shift towards remote monitoring and home healthcare
5.2.1.4 Expanding geriatric population and rising healthcare expenditure
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory guidelines for commercialization of medical devices
5.2.2.2 Concerns associated with data privacy & security
5.2.3 OPPORTUNITIES
5.2.3.1 Development of non-invasive & wearable pressure monitoring devices
5.2.3.2 Expansion of telehealth infrastructure in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Limited availability of skilled professionals
5.3 INDUSTRY TRENDS
5.3.1 INTEGRATION OF WIRELESS CONNECTIVITY AND IOT IN PRESSURE MONITORING DEVICES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 MEMS (Micro-Electro-Mechanical Systems) sensors
5.4.1.2 Wireless connectivity & cloud integration
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 AI & predictive analytics
5.4.2.2 Wearable electronics & flexible materials
5.5 PORTER'S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF BUYERS
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY FRAMEWORK
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.3.1 Japan
5.6.1.3.2 China
5.6.1.3.3 India
5.6.1.4 Latin America
5.6.1.4.1 Brazil
5.6.1.5 Middle East & Africa
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR BLOOD PRESSURE MONITORING MARKET
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 901890, 2020-2025
5.8.2 EXPORT DATA FOR HS CODE 901890, 2020-2025
5.9 PRICING ANALYSIS
5.9.1 INDICATIVE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
5.9.2 INDICATIVE SELLING PRICE TREND OF PRESSURE MONITORING PRODUCTS, BY REGION
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 UNMET NEEDS/END-USER EXPECTATIONS IN PRESSURE MONITORING MARKET
5.13 IMPACT OF AI/GENERATIVE AI ON PRESSURE MONITORING MARKET
5.14 VALUE CHAIN ANALYSIS
5.15 SUPPLY CHAIN ANALYSIS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.17.1 CASE STUDY 1: MEDTRONIC INTEGRATED CRITICAL CARE PLATFORM CAPABILITIES INTO PRESSURE MONITORING DEVICES
5.17.2 CASE STUDY 2: IMPLEMENTATION OF ADVANCED INVASIVE PRESSURE MONITORING SOLUTIONS ACROSS CRITICAL CARE SETTINGS BY GE HEALTHCARE
5.17.3 CASE STUDY 3: ENHANCED ACCURACY & USABILITY IN HOME MONITORING BY OMRON HEALTHCARE
5.18 ADJACENT MARKETS FOR PRESSURE MONITORING MARKET
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.20 INVESTMENT & FUNDING SCENARIO
5.21 IMPACT OF 2025 US TARIFF ON PRESSURE MONITORING MARKET
5.21.1 KEY TARIFF RATES
5.21.2 PRICE IMPACT ANALYSIS
5.21.3 IMPACT ON COUNTRY/REGION
5.21.3.1 North America
5.21.3.1.1 US
5.21.3.2 Europe
5.21.3.3 Asia Pacific
5.21.4 IMPACT ON END-USER INDUSTRIES
5.21.4.1 Hospitals
5.21.4.2 Home care settings
5.21.4.3 Ambulatory care centers

6 PRESSURE MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 BLOOD PRESSURE MONITORS, BY TYPE
6.2.1.1 Sphygmomanometers
6.2.1.1.1 Rising rates of hypertension to boost demand
6.2.1.2 Blood pressure transducers
6.2.1.2.1 Conversion of physiological blood pressure signals into electronic outputs to fuel market
6.2.1.3 Ambulatory blood pressure monitors
6.2.1.3.1 Growing focus on RPM services to drive market
6.2.1.4 Automated blood pressure monitors
6.2.1.4.1 Increasing preference for personalized health management to propel market
6.2.1.5 Cuffless blood pressure monitors
6.2.1.5.1 Integration of technological advancements into wearable devices to fuel market
6.2.2 BLOOD PRESSURE MONITORS, BY TECHNOLOGY
6.2.2.1 Digital blood pressure monitors
6.2.2.1.1 Improved accuracy & precision to support market growth
6.2.2.2 Aneroid blood pressure monitors
6.2.2.2.1 Proven efficacy across clinical settings to boost demand
6.2.2.3 Wearable blood pressure monitors
6.2.2.3.1 Cuff-based blood pressure monitors
6.2.2.3.2 Cuffless blood pressure monitors
6.2.2.3.2.1 Wrist-based monitors
6.2.2.3.2.1.1 Advancements in sensor technology and miniaturization to fuel uptake
6.2.2.3.2.2 Finger-based Monitors
6.2.2.3.2.2.1 Digital integration to accelerate demand
6.2.2.3.2.3 Arm band-based monitors
6.2.2.3.2.3.1 Continuous monitoring and fitness health tracking insights to boost demand
6.2.3 INTRAOCULAR PRESSURE MONITORS
6.2.3.1 Increasing prevalence of glaucoma to boost demand
6.2.4 PULMONARY PRESSURE MONITORS
6.2.4.1 Oximeters
6.2.4.1.1 Rising incidence of respiratory & infectious diseases to propel market
6.2.4.2 Capnography
6.2.4.2.1 Increasing prevalence of COPD and ARDS to support market uptake
6.2.4.3 Spirometers
6.2.4.3.1 Introduction of portable and digital spirometers to aid market growth
6.2.5 INTRACRANIAL PRESSURE MONITORS
6.2.5.1 Surge in neurological disorders to boost demand
6.2.6 OTHER MONITORING DEVICES
6.3 ACCESSORIES
6.3.1 BLOOD PRESSURE ACCESSORIES, BY TYPE
6.3.1.1 Blood pressure/cardiac monitoring accessories
6.3.1.1.1 Blood pressure cuffs
6.3.1.1.1.1 Availability of manual & automatic models to aid market
6.3.1.1.2 Bulbs
6.3.1.1.2.1 Utilized in conjunction with sphygmomanometers for accurate measurement to drive market
6.3.1.1.3 Manometers
6.3.1.1.3.1 Rising demand due to hypertension to support market growth
6.3.1.1.4 Tubes & valves
6.3.1.1.4.1 Focus on accurate measurement in clinical settings to fuel uptake
6.3.1.2 Intraocular pressure monitoring accessories
6.3.1.2.1 Tip covers/Tonocovers
6.3.1.2.1.1 Advancements in ocular surgery to drive market
6.3.1.2.2 Prisms
6.3.1.2.2.1 Increasing incidence of cataracts to fuel uptake
6.3.1.2.3 Sensors
6.3.1.2.3.1 Integration of IOP sensors into clinical practice to support market uptake
6.3.1.3 Pulmonary pressure monitoring accessories
6.3.1.3.1 Mouthpieces
6.3.1.3.1.1 Growing effectiveness in non-invasive ventilation to boost demand
6.3.1.3.2 Filters
6.3.1.3.2.1 Growing emphasis on infection control practices to aid market
6.3.1.3.3 Nasal probes & plugs
6.3.1.3.3.1 Focus on enhanced respiratory airflow and monitoring to fuel market
6.3.1.4 Other pressure monitoring accessories
6.3.2 ACCESSORIES, BY USABILITY
6.3.2.1 Disposable accessories
6.3.2.1.1 Increasing adoption of single-use accessories for patient safety to boost demand
6.3.2.2 Reusable accessories
6.3.2.2.1 Emphasis on sustainable healthcare practices to support market growth

7 PRESSURE MONITORING MARKET, BY PROCEDURE
7.1 INTRODUCTION
7.2 INVASIVE PROCEDURES
7.2.1 ABILITY TO BALANCE CLINICAL ACCURACY & PATIENT SAFETY IN HIGH-ACUITY PRESSURE MONITORING SYSTEMS TO DRIVE MARKET
7.3 NON-INVASIVE PROCEDURES
7.3.1 AI & ML INTEGRATION WITH REAL-MONITORING INSIGHTS TO BOOST DEMAND

8 PRESSURE MONITORING MARKET, BY THERAPEUTIC APPLICATION
8.1 INTRODUCTION
8.2 RESPIRATORY DISORDERS
8.2.1 INCREASING INCIDENCE OF COPD AND ASTHMA TO DRIVE MARKET
8.3 GLAUCOMA
8.3.1 DEVELOPMENT OF MINIMALLY INVASIVE SENSOR-BASED DEVICES TO FUEL UPTAKE
8.4 CARDIAC DISORDERS
8.4.1 HIGH PREVALENCE OF MYOCARDIAL INFARCTION AND HYPERTENSION TO PROPEL MARKET
8.5 NEUROLOGICAL DISORDERS
8.5.1 CASES OF TBHI AND HEMORRHAGE TO FUEL ADOPTION
8.6 DIALYSIS
8.6.1 INCREASING PREVALENCE OF CKD TO SUPPORT MARKET GROWTH
8.7 OTHER THERAPEUTIC APPLICATIONS

9 PRESSURE MONITORING MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO DRIVE MARKET
9.3 AMBULATORY CARE CENTERS
9.3.1 GROWING DEMAND FOR REAL-TIME PATIENT MONITORING ACROSS CRITICAL CARE TO FUEL MARKET
9.4 HOME CARE SETTINGS
9.4.1 ENHANCED PATIENT CONVENIENCE & SAFETY TO PROPEL MARKET
9.5 URGENT CARE SETTINGS
9.5.1 RISING NEED FOR TIMELY DECISION-MAKING FOR TRAUMA CASES TO BOOST DEMAND
9.6 PRIMARY CENTERS
9.6.1 GROWING FOCUS ON ENHANCED PATIENT OUTCOMES TO SUPPORT MARKET UPTAKE
9.7 OTHER END USERS

10 PRESSURE MONITORING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Established healthcare infrastructure and high volume of chronic diseases to drive market
10.2.3 CANADA
10.2.3.1 Favorable government initiatives for digital health integration to boost demand
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increasing cases of hypertension to fuel market
10.3.3 UK
10.3.3.1 High burden of contagious diseases to boost demand
10.3.4 FRANCE
10.3.4.1 Expansive growth in medical devices industry to aid market
10.3.5 ITALY
10.3.5.1 Adoption of cuffless blood pressure monitoring devices to drive market
10.3.6 SPAIN
10.3.6.1 Government initiatives on advanced medical equipment to fuel uptake
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Favorable policies for healthcare modernization to support market growth
10.4.3 JAPAN
10.4.3.1 Increasing geriatric population and rise in age-associated target conditions to boost demand
10.4.4 INDIA
10.4.4.1 Improvements in healthcare infrastructure to fuel market
10.4.5 SOUTH KOREA
10.4.5.1 Growing focus on national health programs and public health initiatives to drive market
10.4.6 AUSTRALIA
10.4.6.1 Increasing funding investments for non-invasive monitoring technologies to boost demand
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growing focus on home healthcare to support market
10.5.3 MEXICO
10.5.3.1 Increasing focus on telehealth integration to drive market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia (KSA)
10.6.2.1.1 Increasing cases of infectious diseases to boost demand
10.6.2.2 United Arab Emirates (UAE)
10.6.2.2.1 Increasing prevalence of CVD to drive market
10.6.2.3 Other GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Procedure type footprint
11.5.5.5 Therapeutic application footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SME players
11.6.5.2 Competitive benchmarking of startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.9 R&D ASSESSMENT OF KEY PLAYERS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & APPROVALS
11.10.2 DEALS
11.10.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MEDTRONIC
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product approvals
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 KONINKLIJKE PHILIPS N.V.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 GE HEALTHCARE
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product approvals
12.1.3.3.2 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 OMRON CORPORATION.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 DRAGERWERK AG & CO. KGAA
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 MnM view
12.1.5.3.1 Key strengths
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses & competitive threats
12.1.6 ABBOTT
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Product approvals
12.1.6.3.2 Deals
12.1.7 BAXTER INTERNATIONAL, INC.
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Expansions
12.1.8 TERUMO CORPORATION
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 BECTON, DICKINSON AND COMPANY (BD)
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 NIHON KOHDEN CORPORATION
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 INTEGRA LIFESCIENCES CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 ZEISS GROUP
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 BOSTON SCIENTIFIC CORPORATION
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 ICU MEDICAL, INC.
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent development
12.1.14.3.1 Deals
12.1.15 MASIMO CORPORATION
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 REICHERT, INC.
12.2.2 NONIN
12.2.3 NATUS
12.2.4 HONSUN
12.2.5 ROSSMAX INTERNATIONAL LTD.
12.2.6 MICROLIFE CORPORATION
12.2.7 A&D COMPANY
12.2.8 PAUL HARTMANN ASIA-PACIFIC LTD.
12.2.9 ICARE FINLAND OY.
12.2.10 IHEALTH LABS INC.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS